M1 Kliniken AG gross margin has been in long-term decline. The average rate of decline per year is -16.7%.
The historical rank and industry rank for M1 Kliniken AG's Gross Margin % or its related term are showing as below:
XTER:M12'
s Gross Margin % Range Over the Past 10 Years
Min: 14.24 Med: 23.05 Max: 40.93
Current: 16.95
During the past 9 years, the highestGross Margin % of M1 Kliniken AG was 40.93%. The lowest was 14.24%. And the median was 23.05%.
XTER:M12's Gross Margin % is ranked worse than 86.37% of 609
companies
in the Healthcare Providers & Services industry
Industry Median: 41.53
vs XTER:M12: 16.95
M1 Kliniken AG had a gross margin of 16.33% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for M1 Kliniken AG was -16.70% per year.
M1 Kliniken AG Gross Margin % Historical Data
The historical data trend for M1 Kliniken AG's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of M1 Kliniken AG's Gross Margin %
For the Medical Care Facilities subindustry, M1 Kliniken AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG's Gross Margin % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, M1 Kliniken AG's Gross Margin % distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
M1 Kliniken AG (XTER:M12) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
M1 Kliniken AG had a gross margin of 16.33% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
M1 Kliniken AG Gross Margin % Related Terms
Thank you for viewing the detailed overview of M1 Kliniken AG's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. Majority of its revenue derived from Trade segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:M12 has been successfully added to your 